BG64560B1 - Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства - Google Patents
Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства Download PDFInfo
- Publication number
- BG64560B1 BG64560B1 BG102836A BG10283698A BG64560B1 BG 64560 B1 BG64560 B1 BG 64560B1 BG 102836 A BG102836 A BG 102836A BG 10283698 A BG10283698 A BG 10283698A BG 64560 B1 BG64560 B1 BG 64560B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- group
- hydrogen
- substituted
- dream
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0071696A AT403803B (de) | 1996-04-19 | 1996-04-19 | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
Publications (2)
Publication Number | Publication Date |
---|---|
BG102836A BG102836A (en) | 1999-09-30 |
BG64560B1 true BG64560B1 (bg) | 2005-07-29 |
Family
ID=3497932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102836A BG64560B1 (bg) | 1996-04-19 | 1998-10-12 | Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства |
Country Status (12)
Country | Link |
---|---|
US (2) | US6638925B2 (fr) |
EP (2) | EP1757608A1 (fr) |
AT (1) | AT403803B (fr) |
AU (1) | AU2498597A (fr) |
BG (1) | BG64560B1 (fr) |
CZ (1) | CZ300211B6 (fr) |
IS (1) | IS4839A (fr) |
NO (1) | NO324211B1 (fr) |
PL (2) | PL189834B1 (fr) |
RO (1) | RO120136B1 (fr) |
TW (1) | TWI224595B (fr) |
WO (1) | WO1997040049A1 (fr) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403803B (de) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
US7214686B2 (en) * | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
AU1430099A (en) * | 1998-12-01 | 2000-06-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage |
CA2365258A1 (fr) * | 1999-05-04 | 2000-11-09 | Neurosearch A/S | Diazabicycloalcanes heteroaryles, leur preparation et leur utilisation |
CZ300160B6 (cs) | 2000-03-31 | 2009-02-25 | Sanochemia Pharmazeutika Aktiengesellschaft | Deriváty galanthaminu, zpusob výroby techto derivátu, lécivo, které tyto deriváty obsahuje, použitítechto derivátu pro výrobu léciva, zpusob výroby tohoto léciva a zpusob separace (+)- a (-)-izomeruuvedených derivátu |
KR100768245B1 (ko) * | 2000-03-31 | 2007-10-17 | 자노케미아 파마조이티카 악티엔게젤샤프트 | 신규한 갈란타민 유도체 및 유사체 |
DE60109924T2 (de) | 2000-05-25 | 2006-02-09 | Targacept, Inc. | Heteroaryldiazabicycloalkane als liganden für den nikotinischen acetylcholin-rezeptor |
US6440970B1 (en) * | 2000-05-25 | 2002-08-27 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
AU6583101A (en) | 2000-07-04 | 2002-01-14 | Neurosearch As | Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
PL362077A1 (en) * | 2000-10-19 | 2004-10-18 | Pfizer Products Inc. | Bridged piperazine derivatives |
CA2431181A1 (fr) * | 2000-12-07 | 2002-06-13 | Nobuya Matsuoka | Nootropes |
CN1703401A (zh) * | 2001-05-22 | 2005-11-30 | 神经原公司 | 黑色素浓集激素受体的配体:取代的1-苄基-4-芳基哌嗪类似物 |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
JP4721386B2 (ja) * | 2001-07-10 | 2011-07-13 | 第一三共株式会社 | 新規ガランタミン類縁体 |
DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
ES2355157T3 (es) * | 2002-07-05 | 2011-03-23 | Targacept, Inc. | Compuestos diazaspirocíclico n-arilo y métodos de preparación y uso de las mismas. |
WO2004009775A2 (fr) | 2002-07-19 | 2004-01-29 | Targacept, Inc. | Methodes et compositions associees a des sous-unites de recepteurs nicotiniques chimeriques |
US7098331B2 (en) * | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
JPWO2005027968A1 (ja) * | 2003-09-19 | 2007-11-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ダウン症候群治療剤 |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
PT1678172E (pt) * | 2003-10-15 | 2010-03-03 | Targacept Inc | Composições farmacêuticas e métodos para alívio da dor e tratamento de perturbações do sistema nervoso central |
AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
US20070004679A1 (en) * | 2004-05-17 | 2007-01-04 | Nathalie Schlienger | Androgen receptor modulators and methods of treating disease using the same |
US7268232B2 (en) * | 2004-05-17 | 2007-09-11 | Acadia Pharmaceuticals Inc. | Androgen receptor modulators and method of treating disease using the same |
US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
CN101044134A (zh) * | 2004-09-20 | 2007-09-26 | 塔加西普特公司 | 具有烟碱性胆碱能受体活性的氮杂螺烯和氮杂螺烷化合物 |
KR20070105967A (ko) | 2004-11-03 | 2007-10-31 | 아이리스 몰레큘라 다이아그노스틱스, 인코오포레이티드 | 균질 분석물 탐지 |
CN101065497B (zh) | 2004-11-03 | 2012-11-21 | 卢卡迪亚技术股份有限公司 | 用于亲和分离的微泡 |
US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
UA88792C2 (ru) | 2004-11-10 | 2009-11-25 | Таргасепт, Інк. | Гидроксибензоатные соли метаникотиновых соединений |
ITMI20042413A1 (it) * | 2004-12-17 | 2005-03-17 | Indena Spa | Processo per la preparazione di galantamina bromidrato |
WO2006072818A2 (fr) * | 2005-01-04 | 2006-07-13 | Emcure Pharmaceuticals Limited | Procede pour preparer de la benzazepine |
US20060173037A1 (en) * | 2005-01-10 | 2006-08-03 | Nathalie Schlienger | Aminophenyl derivatives as selective androgen receptor modulators |
CN101119993B (zh) * | 2005-01-10 | 2015-03-04 | 阿卡蒂亚药品公司 | 作为选择性雄激素受体调节剂的氨基苯基衍生物 |
US20100168081A1 (en) * | 2005-08-11 | 2010-07-01 | Adriana Di Polo | Galantamine as a neuroprotective drug for retinal ganglion cells |
WO2007024814A1 (fr) * | 2005-08-22 | 2007-03-01 | Targacept, Inc. | Diazatricycloalkanes substitues heteroaryle, procedes d'obtention et methodes d'utilisation |
US20070213318A1 (en) * | 2006-03-07 | 2007-09-13 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
EP1777222A1 (fr) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Inhibiteurs de la cholinesterase avec une perméabilité améliorée de la barrière ématoencéphalique pour le traitement de troubles cognitifs |
US20090253654A1 (en) * | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
CA2632027A1 (fr) | 2005-12-14 | 2007-06-21 | Amgen Inc. | Derives diaza heterocycliques de sulfonamide et leurs utilisations |
US8672732B2 (en) * | 2006-01-19 | 2014-03-18 | Schneider Electric It Corporation | Cooling system and method |
CN100384850C (zh) * | 2006-04-14 | 2008-04-30 | 浙江大学 | 加兰他敏衍生物及制备方法和用途 |
TWI389889B (zh) * | 2006-05-09 | 2013-03-21 | Targacept Inc | (2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型 |
US8017785B2 (en) * | 2006-05-09 | 2011-09-13 | Astrazeneca Ab | Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine |
DK2041088T3 (da) | 2006-06-28 | 2014-04-07 | Amgen Inc | Glycintransporter-1 inhibitorer |
CL2007002684A1 (es) * | 2006-09-15 | 2008-06-27 | Astrazeneca Ab Targacept Inc | Combinacion que comprende un antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina; composicion farmaceutica que la comprende; kit farmaceutico; y uso para tratar perjuicio cognitivo y/o trastorno psicoticos. |
US20100028447A1 (en) * | 2007-01-22 | 2010-02-04 | Targacept, Inc. | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
RU2010107278A (ru) * | 2007-07-31 | 2011-09-10 | Таргасепт, Инк. (Us) | Трансдермальное введение (2s)-(4е)-n-метил-5-(3-(5-изопропоксипиридин)ил)-4-пентен-2-амина |
KR101565469B1 (ko) | 2007-10-01 | 2015-11-03 | 코멘티스, 인코포레이티드 | 알츠하이머병의 치료를 위한 알파 7 니코틴 아세틸콜린 수용체 리간드로서 퀴누클리딘-4-일메틸 1h-인돌-3-카르복실레이트 유도체 |
DK2137192T3 (da) | 2008-04-14 | 2014-05-26 | Neurodyn Life Sciences Inc | Derivater af galantamin som prodrugs til behandling af humane hjernesygdomme |
WO2011071758A1 (fr) | 2009-12-07 | 2011-06-16 | Targacept, Inc. | 3,6-diazabicyclo[3.1.1]heptanes comme ligands des récepteurs nicotiniques neuronaux à l'acétycholine |
MX2012013193A (es) | 2010-05-20 | 2012-12-17 | Astrazeneca Ab | Nuevo proceso para preparar aminas olefinicas sustituidas con arilo. |
WO2013160728A1 (fr) | 2012-04-26 | 2013-10-31 | Alma Mater Studiorum - Universita' Di Bologna | Composés à double ciblage pour le traitement de la maladie d'alzheimer |
CN104447767B (zh) * | 2013-09-24 | 2018-08-03 | 连云港金康医药科技有限公司 | 氮杂双环[3,2,1]辛烷衍生物及其应用 |
TW201617342A (zh) | 2014-07-11 | 2016-05-16 | 阿法馬根公司 | 調節α7活性之啶類 |
US10414778B2 (en) * | 2016-04-29 | 2019-09-17 | New Mexico Tech University Research Park Corporation | Methods for treatment of resistant cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0236684A2 (fr) * | 1986-01-15 | 1987-09-16 | Synaptech, Inc. | Galanthamine ou ses analogues pour le traitement de la maladie d'Alzheimer |
WO1995027715A2 (fr) * | 1994-04-08 | 1995-10-19 | Ciba-Geigy Corporation | Procede de production a haut rendement de galanthamine (-) tres pure essentiellement exempte d'epigalanthamine |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947445A (en) | 1974-05-09 | 1976-03-30 | Stanford Research Institute | Diazabicyclooctanes and diazabicycloheptanes |
JP2755403B2 (ja) | 1987-05-04 | 1998-05-20 | デイービス、ボニー | アルツハイマー病の治療のための化合物 |
GB8800694D0 (en) | 1988-01-13 | 1988-02-10 | Pfizer Ltd | Antiarrhythmic agents |
NL8800350A (nl) | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
US4954502A (en) | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
CA2012681A1 (fr) | 1989-03-31 | 1990-09-30 | Masayasu Okuhira | Derives de la quinolone, procedes de preparation et agents antibacteriens les renfermant |
US5036153A (en) | 1989-05-11 | 1991-07-30 | Braish Tamim F | Preparation of 2,5-diazabicyclo[2.2.1]heptanes and intermediates |
US4994460A (en) | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
DK0507861T3 (fr) | 1989-12-28 | 1997-03-03 | Upjohn Co | |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
HU213097B (en) | 1991-05-14 | 1997-02-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing phenylpiperazines |
US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
US6323196B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6316439B1 (en) | 1993-10-15 | 2001-11-13 | Aventis Pharamaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6323195B1 (en) | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
US6407229B1 (en) | 1994-10-21 | 2002-06-18 | Sanochemia Pharmazeutika Ag | Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine |
ES2106700T3 (es) * | 1994-10-21 | 2000-05-16 | Sanochemia Pharmazeutika Ag | Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas. |
AT401058B (de) | 1994-10-21 | 1996-06-25 | Waldheim Pharmazeutika Gmbh | Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins |
GB9519268D0 (en) | 1995-09-21 | 1995-11-22 | Chiroscience Ltd | Preparation of alkaloids |
AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
AU1430099A (en) | 1998-12-01 | 2000-06-19 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage |
AT414125B (de) | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
-
1996
- 1996-04-19 AT AT0071696A patent/AT403803B/de not_active IP Right Cessation
-
1997
- 1997-04-21 RO RO98-01487A patent/RO120136B1/ro unknown
- 1997-04-21 PL PL97329411A patent/PL189834B1/pl not_active IP Right Cessation
- 1997-04-21 EP EP06025028A patent/EP1757608A1/fr not_active Withdrawn
- 1997-04-21 EP EP97916263A patent/EP0897387A1/fr not_active Ceased
- 1997-04-21 WO PCT/AT1997/000074 patent/WO1997040049A1/fr not_active Application Discontinuation
- 1997-04-21 CZ CZ0332498A patent/CZ300211B6/cs not_active IP Right Cessation
- 1997-04-21 PL PL97361697A patent/PL190032B1/pl not_active IP Right Cessation
- 1997-04-21 AU AU24985/97A patent/AU2498597A/en not_active Abandoned
- 1997-04-21 US US09/242,339 patent/US6638925B2/en not_active Expired - Fee Related
- 1997-05-09 TW TW086106195A patent/TWI224595B/zh not_active IP Right Cessation
-
1998
- 1998-08-28 IS IS4839A patent/IS4839A/is unknown
- 1998-10-12 BG BG102836A patent/BG64560B1/bg unknown
- 1998-10-16 NO NO19984852A patent/NO324211B1/no not_active IP Right Cessation
-
2003
- 2003-08-26 US US10/647,283 patent/US7101890B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0236684A2 (fr) * | 1986-01-15 | 1987-09-16 | Synaptech, Inc. | Galanthamine ou ses analogues pour le traitement de la maladie d'Alzheimer |
WO1995027715A2 (fr) * | 1994-04-08 | 1995-10-19 | Ciba-Geigy Corporation | Procede de production a haut rendement de galanthamine (-) tres pure essentiellement exempte d'epigalanthamine |
Also Published As
Publication number | Publication date |
---|---|
TWI224595B (en) | 2004-12-01 |
EP0897387A1 (fr) | 1999-02-24 |
IS4839A (is) | 1998-08-28 |
US20030092700A1 (en) | 2003-05-15 |
AU2498597A (en) | 1997-11-12 |
NO324211B1 (no) | 2007-09-10 |
US6638925B2 (en) | 2003-10-28 |
NO984852L (no) | 1998-11-16 |
PL329411A1 (en) | 1999-03-29 |
RO120136B1 (ro) | 2005-09-30 |
PL190032B1 (pl) | 2005-10-31 |
US20040067974A1 (en) | 2004-04-08 |
CZ300211B6 (cs) | 2009-03-18 |
US7101890B2 (en) | 2006-09-05 |
BG102836A (en) | 1999-09-30 |
AT403803B (de) | 1998-05-25 |
EP1757608A1 (fr) | 2007-02-28 |
CZ332498A3 (cs) | 1999-05-12 |
WO1997040049A1 (fr) | 1997-10-30 |
PL189834B1 (pl) | 2005-09-30 |
ATA71696A (de) | 1997-10-15 |
NO984852D0 (no) | 1998-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG64560B1 (bg) | Бензазепинови производни, лекарствени средства, които ги съдържат, и тяхното приложение за получаването на лекарства | |
US6774132B1 (en) | Spirooxindole derivatives that act as analgesics | |
RU2104269C1 (ru) | Производные изоиндолона или их соли с кислотами в качестве промежуточных соенинений для синтеза биологически активных соединений - пергидроизоиндолонов | |
KR101050700B1 (ko) | 칼슘 수용체 조절 화합물 및 이의 용도 | |
JPS62201882A (ja) | イソフラボン誘導体 | |
EP0787115B1 (fr) | PROCEDE DE PREPARATION DE DERIVES DE 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE | |
CZ410791A3 (en) | Amides of thieno-triazolo-1,4-diazepino-2-carboxylic acid, process of their preparation and pharmaceutical preparation based thereon | |
EP0091241A2 (fr) | Dérivés condensés de pyrrolinone, et leur préparation | |
SK279298B6 (sk) | Deriváty camptothecinu, spôsob ich výroby, farmace | |
AU640300B2 (en) | Pharmacologically active substituted oxybenzamides | |
BG65134B1 (bg) | Производни и аналози на галантамин | |
EP0174858B1 (fr) | Dérivés de l'isoindolinone, leur préparation et leur utilisation | |
US5075317A (en) | Spirofurane derivatives | |
Trauner | New ventures in the construction of complex heterocycles: synthesis of morphine and hasubanan alkaloids | |
AU597083B2 (en) | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties | |
FI72514C (fi) | Foerfarande foer framstaellning av nya antiallergiska bensoxazol- och bensotiazol-2-karboxylsyraestrar. | |
US4965259A (en) | Dioxazocine derivatives compositions and methods containing them having antidepressive, spasmolytic, anticonvulsive, and antiarrhythmic properties | |
US4591587A (en) | Cyclopropyl pyridine compounds useful as calcium channel blockers | |
FI79322C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-fenyl-isoxazolo/4,5-c/kinolin-3-oner. | |
US4318909A (en) | Benzoxazocines | |
US4235901A (en) | 1-Hydroxyalkanamine pyrano(3,4-b)indole compositions and use thereof | |
US3857854A (en) | 6-phenyl-1h,4h-{8 1,2,4{9 oxadiazalo{8 4,3-2{9 {8 1,4{9 benzodiazepin-1-ones | |
US4626522A (en) | Benzoxazocines intermediates | |
US3555012A (en) | Dibenzothiadiazocine derivatives | |
PREPARE | Czollner et aI. |